SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-006990
Filing Date
2019-05-14
Accepted
2019-05-14 06:16:34
Documents
40
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 311995
2 ex31-1.htm EX-31.1 17471
3 ex31-2.htm EX-31.2 17462
4 ex32-1.htm EX-32.1 6539
5 ex32-2.htm EX-32.2 6480
  Complete submission text file 0001493152-19-006990.txt   2041269

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE nxen-20190331.xml EX-101.INS 266724
7 XBRL SCHEMA FILE nxen-20190331.xsd EX-101.SCH 31851
8 XBRL CALCULATION FILE nxen-20190331_cal.xml EX-101.CAL 24942
9 XBRL DEFINITION FILE nxen-20190331_def.xml EX-101.DEF 107090
10 XBRL LABEL FILE nxen-20190331_lab.xml EX-101.LAB 231471
11 XBRL PRESENTATION FILE nxen-20190331_pre.xml EX-101.PRE 159783
Mailing Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246
Business Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246 3034957583
NEXIEN BIOPHARMA, INC. (Filer) CIK: 0001625288 (see all company filings)

IRS No.: 262049376 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55320 | Film No.: 19820357
SIC: 2834 Pharmaceutical Preparations